Stock Alert: AspenBio Pharma, Inc. (APPY) Rises 51%

Shares of AspenBio Pharma, Inc. (NASDAQ:APPY) continued to move higher and now up 51% to $0.863 after rising over 50% in yesterday's session. More than 1.73 million shares have traded hands, compared to its average. This morning, the company said it has started manufacturing of its AppyScore(TM) cassette-based test system to be used in further validation and verification testing of AppyScore — a novel, blood-based diagnostic test designed to aid emergency department physicians in the difficult challenge of evaluating patients suspected of having appendicitis. Initial pre-clinical market testing is expected to start prior to the end of the fiscal year. AspenBio Pharma, Inc. (AspenBio) is a bio-pharmaceutical company dedicated to the discovery, development, manufacture, and marketing of products. The Company is primarily focused on commercialization of blood-based human diagnostic test, AppyScore to aid in the evaluation of acute appendicitis, as well as several reproduction drugs for use in animals and livestock production. Disclaimer: The assembled information distributed by epicstockpicks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Epicstockpicks.com does expect that investors will buy and sell securities based on information assembled and presented herein. EpicStockPicks.com will not be responsible in any way for or accept any liability for any losses arising from an investor's reliance on or use of information obtained from our website or emails. PLEASE always do your own due diligence, and consult your financial advisor.
tdp2664
Epic Stock Picks